146
M.-A. Lassoie et al. / Bioorg. Med. Chem. Lett. 17 (2007) 142–146
W. R.; Chi, E. Y.; Albert, R. K.; Chu, S. J.; Lamm, W. J.;
Rochon, Y.; Jonas, M.; Christie, P. E.; Harlan, J. M.
G.; Sheffron, A.; Chen, L.; Campbell, R.; Guthrie, R.;
Huang, T. N.; Huby, N.; Rowan, K.; Schwinge, V.;
Renzetti, L. M. Bioorg. Med. Chem. Lett. 2002, 12, 2475;
(i) Chen, L.; Tilley, J. W.; Trilles, R. V.; Yun, W.; Fry, D.;
Cook, C.; Rowan, K.; Schwinge, V.; Campbell, R. Bioorg.
Med. Chem. Lett. 2002, 12, 137; (j) Porter, J. R.;
Archibald, S. C.; Childs, K.; Critchley, D.; Head, J. C.;
Linsley, J. M.; Parton, T. A.; Robinson, M. K.; Shock, A.;
Taylor, R. J.; Warrellow, G. J.; Alexander, R. P.;
Langham, B. Bioorg. Med. Chem. Lett. 2002, 12, 1051;
(k) Sircar, I.; Gudmundsson, K. S.; Martin, R.; Liang, J.;
Nomura, S.; Jayakumar, H.; Teegarden, B. R.; Nowlin, D.
M.; Cardarelli, P. M.; Mah, J. R.; Connell, S.; Griffith, R.
C.; Lazarides, E. Bioorg. Med. Chem. 2002, 10, 2051; (l)
Gutteridge, C. E.; de Laszlo, S. E.; Kamenecka, T. M.;
McCauley, E.; Van Riper, G.; Mumford, R. A.; Kidambi,
U.; Egger, L. A.; Tong, S.; Hagmann, W. K. Bioorg. Med.
Chem. Lett. 2003, 13, 885; (m) Hoshina, Y.; Ikegami, S.;
Okuyama, A.; Fukui, H.; Inoguchi, K.; Maruyama, T.;
Fujimoto, K.; Matsumura, Y.; Aoyama, A.; Harada, T.;
Tanaka, H.; Nakamura, T. Bioorg. Med. Chem. Lett.
2005, 15, 217; (n) Witherington, J.; Bordas, V.; Gaiba, A.;
Green, P. M.; Naylor, A.; Parr, N.; Smith, D. G.; Takle,
A. K.; Ward, R. W. Bioorg. Med. Chem. Lett. 2006, 16,
2256.
J. Clin. Invest. 1997, 100, 3083.
5. Keszthelyi, E.; Karlik, S.; Hydruk, S.; Rice, G. P.;
Gordon, G.; Yednock, T.; Horner, H. Neurology 1996,
47, 1053.
6. (a) Ianaro, A.; Cicala, C.; Calignano, A.; Koteliansky, V.;
Gotwals, P.; Bucci, M.; Gerli, R.; Santucci, L.; Fiorucci,
S.; Cirino, G. Lab. Invest. 2000, 80, 73; (b) Finkenauer, V.;
Bissinger, T.; Funk, R. H.; Karbowski, A.; Seiffge, D.
Microcirculation 1999, 6, 141.
7. Tilley, J. W. Expert Opin. Ther. Patents 2002, 12, 991.
8. Podolsky, D. K.; Lobb, R. R.; King, N.; Benjamin, C. D.;
Pepinsky, B.; Sehgal, P.; de Beaumont, M. J. Clin. Invest.
1993, 92, 372.
9. (a) Bocchino, V.; Bertorelli, G.; D’Ippolito, R.; Castag-
naro, A.; Zhuo, X.; Grima, P.; DiComite, V.; Darnia, K.;
Olivieri, D. J. Allergy Clin. Immunol. 2000, 105, 65; (b)
Tomita, K.; Tanigawa, T.; Yajima, H.; Sano, H.; Fuku-
tani, K.; Hitsuda, Y.; Matsumoto, Y.; Sasaki, T. Clin.
Exp. Allergy 1997, 27, 664; (c) Ohkawara, Y.; Yamauchi,
K.; Maruyama, N.; Hoshi, H.; Ohno, I.; Honma, M.;
Tanno, Y.; Tamura, G.; Shirato, K.; Ohtani, H. Am. J.
Respir. Cell Mol. Biol. 1995, 12, 4; (d) Gosset, P.; Tillie-
Leblond, I.; Janin, A.; Marquette, C. H.; Copin, M. C.;
Wallaert, B.; Tonnel, A. B. Int. Arch. Allergy Immunol.
1995, 106, 69; (e) Zangrilli, J. G.; Shaver, J. R.; Cirelli, R.
A.; Cho, S. K.; Garlisi, C.; Falcone, A.; Cuss, F. M.; Fish,
J. E.; Peters, S. P. Am. J. Respir. Crit. Care Med. 1995,
151, 1346; (f) Fukuda, T.; Fukushima, Y.; Numao, T.;
Ando, N.; Arima, M.; Nakajima, H.; Sagara, H.; Adachi,
T.; Motojima, S.; Makino, S. Am. J. Respir. Cell Mol.
Biol. 1996, 14, 84.
12. Demaude, T.; Knerr, L.; Pasau, P. J. Comb. Chem. 2004,
6, 768.
13. Kobayashi, S.; Ishitani, H.; Nagayama, S. Synthesis 1995,
1195.
14. For R1 and R2 = 2,6-diClPh: Chiralpak AD
100 · 500 mm, flow: 300 mL/min, wavelength: 220 nm;
hexane/ethanol 50/50 as eluent.
15. Arcadi, A.; Cacchi, S.; Marinelli, F.; Morera, E.; Ortar, G.
Tetrahedron 1990, 46, 7151.
16. Goodall, K.; Parsons, A. F. J. Chem. Res. Synop. 2000, 2,
54.
10. (a) Steinman, L. Nat. Rev. Drug Discov. 2005, 4, 510; (b)
Elices, M. J. Curr. Opin. Invest. Drugs 2003, 4, 1354; (c)
Rice, G. P. A.; Hartung, H.-P.; Calabresi, P. A. Neurology
2005, 64, 1336.
17. The VLA-4 expressing cell line U937 (ATCC nꢁ: CRL
1593) was cultured in RPMI 1640 medium supplemented
with fetal bovine serum 10%. Prior to the assay, cells were
washed, resuspended in HBSS BSA 0.1% at 5 · 106 cells/
mL, and loaded with the fluorescent dye Calcein-AM at a
final concentration of 10 lmol/L for 15 min at 37 ꢁC. After
washing, cells were resuspended in RPMI at 2 · 106 cells/
mL for assay. Cells were plated in 96-well microtiter
plates, precoated with soluble human recombinant
VCAM-1 (2.5 lg/mL in DPBS), in the presence of test
compounds or vehicle (DMSO, 1% final concentration).
Plates were then incubated at room temperature for
45 min. After washings, adherent cells were quantified by
fluorescence measurement and expressed in percentage of
total cells. Adhesion inhibition was calculated for each test
compound concentration run in triplicate. IC50 were
evaluated from three independent titration curves and
expressed as mean value.
18. Chen, L.; Trilles, R. V.; Miklowski, D.; Huang, T. N.;
Fry, D.; Campbell, R.; Rowan, K.; Schwinge, V.; Tilley, J.
W. Bioorg. Med. Chem. Lett. 2002, 12, 1679.
19. Whole blood samples were incubated with fluorescently
labeled VCAM ligand for 30 min at room temperature in
the presence or absence of titrated inhibitor. After lysis of
red blood cells, leukocytes were washed and the amount of
bound ligand assessed by flow cytometry. Inhibition of
ligand binding was associated with a decrease in fluores-
cent signal.
11. (a) Holland, G. W.; Biediger, R. J.; Vanderslice, P. In
Annual Reports in Medicinal Chemistry; Doherty, A. M.,
Eds.; Academic Press, an imprint of Elsevier Science,
2002; Vol. 37, pp 65–74; (b) Kamenecka, T. M.; Lanza, T.,
Jr.; de Laszlo, S. E.; Li, B.; McCauley, E. D.; Van Riper,
G.; Egger, L. A.; Kidambi, U.; Mumford, R. A.; Tong, S.;
MacCoss, M.; Schmidt, J. A.; Hagmann, W. K. Bioorg.
Med. Chem. Lett. 2002, 12, 2205; (c) Li, B.; de Laszlo, S.
E.; Kamenecka, T. M.; Kopka, I. E.; Durette, P. L.;
Lanza, T., Jr.; MacCoss, M.; Tong, S.; Mumford, R. A.;
McCauley, E. D.; Van Riper, G.; Schmidt, J. A.;
Hagmann, W. K. Bioorg. Med. Chem. Lett. 2002, 12,
2141; (d) Doherty, G. A.; Yang, G. X.; Borges, E.; Chang,
L. L.; Tong, S.; Kidambi, U.; Egger, L. A.; McCauley, E.;
Van Riper, G.; Mumford, R. A.; Schmidt, J. A.;
Hagmann, W. K. Bioorg. Med. Chem. Lett. 2002, 12,
1501; (e) Yang, G. X.; Chang, L. L.; Truong, Q.; Doherty,
G. A.; Magriotis, P. A.; deLaszlo, S. E.; Li, B.; MacCoss,
M.; Kidambi, U.; Egger, L. A. Bioorg. Med. Chem. Lett.
2002, 12, 1497; (f) Kopka, I. E.; Young, D. N.; Lin, L. S.;
Mumford, R. A.; Magriotis, P. A.; MacCoss, M.; Mills, S.
G.; Van Riper, G.; McCauley, E.; Egger, L. A.; Kidambi,
U.; Schmidt, J. A.; Lyons, K.; Stearns, R.; Vincent, S.;
Colletti, A.; Wang, Z.; Tong, S.; Wang, J.; Zheng, S.;
Owens, K.; Levorse, D.; Hagmann, W. K. Bioorg. Med.
Chem. Lett. 2002, 12, 637; (g) Sidduri, A.; Tilley, J. W.;
Lou, J. P.; Chen, L.; Kaplan, G.; Mennona, F.; Campbell,
R.; Guthrie, R.; Huang, T. N.; Rowan, K.; Schwinge, V.;
Renzetti, L. M. Bioorg. Med. Chem. Lett. 2002, 12, 2479;
(h) Sidduri, A.; Tilley, J. W.; Hull, K.; Lou, J. P.; Kaplan,
20. Lassoie, M.-A.; Knerr, L.; Demaude, T.; de Laveleye-
´ ´
Defais, F.; Kogej, T.; Routier, S.; Guillaumet, G.; Quere,
L. European Patent Application EP1501801 A1.